The following are a selection of current articles written by faculty in the Section on Endocrinology and Metabolism:
2008
Crouse JR. An evaluation of rosuvastatin: pharmacokinetics, clinical efficacy and tolerability. Expert Opin Drug Metab Toxicol. 2008 Mar;4(3):287-304.
Ginsberg HN, Bonds DE, Lovato LC, Crouse JR, Elam MB, Linz PE, O'connor PJ, Leiter LA, Weiss D, Lipkin E, Fleg JL; ACCORD Study Group. Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18;99(12A):56i-67i. Epub 2007 Apr 12.
Yeboah J, Sutton-Tyrrell K, Mcburnie MA, Burke GL, Herrington DM, Crouse JR. Association between brachial artery reactivity and cardiovascular disease status in an elderly cohort: the cardiovascular health study. Atherosclerosis. 2008 Apr;197(2):768-76. Epub 2007 Aug 21.
Yeboah J, Burke GL, Crouse JR, Herrington DM. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study. Atherosclerosis. 2008 Apr;197(2):840-5. Epub 2007 Sep 4.
2007 Terry JG, Carr JJ, Kouba EO, Davis DH, Menon L, Bender K, Chandler ET, Morgan T, Crouse JR 3rd. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am J Cardiol. 2007 Jun 15;99(12):1714-7. Epub 2007 Apr 26. | Faculty Research Interests Are Diverse K. Patrick Ober, M.D., FACP.—Dr. Ober has written on numerous topics dealing with clinical endocrinology, including subjects such as thyrotoxic periodic paralysis, lymphocytic hypophysitis, diabetes insipidus, novel approaches to therapy of hirsutism, struma cordis, acanthosis nigricans and endocrine disorders, adrenal insufficiency, pituitary apoplexy, pheochromocytoma, and the toxicity of endocrine therapeutic agents. Reflecting his diverse medical interests, he has also written papers on clinical problem solving and on Mark Twain's perspectives on 19th century medicine. John R. Crouse, III, M.D. Dr. Crouse's important academic contributions include establishment of use of B-mode ultrasound for quantification of subclinical atherosclerosis in epidemiologic studies and clinical trials, and identification of statin treatment as a means of reducing risk of stroke. His current NIH-funded research includes (1) a clinical trial to test the hypothesis that treatment with azithromycin reduces the risk of CHD; (2) a study to test the hypothesis that impairment of vascular function identifies older individuals at increased risk of CHD; and, (3) an epidemiologic evaluation of interassociations between indices of arterial structure and function in patients with defined coronary status. |